Provided by Tiger Fintech (Singapore) Pte. Ltd.

Vigil Neuroscience, Inc.

7.89
0.0000
Volume:231.44K
Turnover:1.83M
Market Cap:368.24M
PE:-3.84
High:7.89
Open:7.88
Low:7.88
Close:7.89
Loading ...

Vigil Neuroscience Cut to Market Perform From Outperform by William Blair

Dow Jones
·
22 May

Vigil Neuroscience Cut to Neutral From Outperform by Wedbush

Dow Jones
·
22 May

Vigil Neuroscience Shares Surge After Sanofi's Planned Acquisition

Dow Jones
·
22 May

BUZZ-Vigil Neuroscience surge after Sanofi to buy co in $470 million deal

Reuters
·
22 May

Wedbush Downgrades Vigil Neuroscience to Neutral From Outperform, Cuts Price Target to $8 From $13

MT Newswires Live
·
22 May

Vigil Neuroscience Shares up 246% at $7.99 Premarket After Sanofi to Buy Co in $470 Mln Deal

THOMSON REUTERS
·
22 May

Vigil Neuroscience downgraded to Neutral from Outperform at Wedbush

TIPRANKS
·
22 May

Vigil Neuroscience Inc. Announces New Voting and Support Agreement with Sanofi for Upcoming Merger

Reuters
·
22 May

Sanofi to Acquire Vigil Neuroscience for Up to $600 Million

MT Newswires Live
·
22 May

PRESS DIGEST -Wall Street Journal - May 22

Reuters
·
22 May

Sanofi to Buy Vigil Neuroscience for About $470 Million

Dow Jones
·
22 May

Vigil Neuroscience to be acquired by Sanofi for $8.00 per share

TIPRANKS
·
22 May

Sanofi to Acquire Vigil Neuroscience in $600 Million Deal, Strengthening Alzheimer's Treatment Pipeline

Reuters
·
22 May

Vigil Neuroscience Enters Into Definitive Merger Agreement to Be Acquired by Sanofi

THOMSON REUTERS
·
22 May

REFILE-Sanofi to acquire Vigil Neuroscience in $470 million deal

Reuters
·
22 May

BRIEF-Sanofi To Acquire Vigil Neuroscience For $8 Per Share, Equity Value $470 Million

Reuters
·
22 May

Sanofi to Acquire Vigil Neuroscience, Expanding Alzheimer's Treatment Pipeline with VG-3927

Reuters
·
22 May

Vigil Neuroscience Q1 EPS $(0.49) Beats $(0.53) Estimate

Benzinga
·
07 May

BRIEF-Vigil Neuroscience Q1 EPS USD -0.49 Vs. IBES Estimate USD -0.53

Reuters
·
07 May

Press Release: Vigil Neuroscience Reports First Quarter 2025 Financial Results and Provides Recent Business Updates

Dow Jones
·
07 May